Impact of amyloid PET in the clinical care of veterans in a tertiary memory disorders clinic.
Ana Laura Vives-RodriguezKylie A SchiloskiAnna MarinRyan WangGabor P HajosRachel PowsnerRenée DeCaroAndrew E BudsonKatherine W TurkPublished in: Alzheimer's & dementia (New York, N. Y.) (2022)
Amyloid PET was associated with longer follow-up, and higher diagnostic variability.No association was seen with cholinesterase inhibitors prescription, or referrals to research.In complex patients, expected amyloid PET positivity rates are lower than previously described.Amyloid PETs were used to "rule out" AD than to confirm the diagnosis of AD.